IBDEI0NF ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11526,0)
 ;;=323.9^^76^756^7
 ;;^UTILITY(U,$J,358.3,11526,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11526,1,1,0)
 ;;=1^323.9
 ;;^UTILITY(U,$J,358.3,11526,1,2,0)
 ;;=2^ENCEPHALITIS/MYELITIS
 ;;^UTILITY(U,$J,358.3,11526,2)
 ;;=^334231
 ;;^UTILITY(U,$J,358.3,11527,0)
 ;;=421.9^^76^756^8
 ;;^UTILITY(U,$J,358.3,11527,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11527,1,1,0)
 ;;=1^421.9
 ;;^UTILITY(U,$J,358.3,11527,1,2,0)
 ;;=2^ENDOCARDITIS
 ;;^UTILITY(U,$J,358.3,11527,2)
 ;;=^269701
 ;;^UTILITY(U,$J,358.3,11528,0)
 ;;=422.90^^76^756^9
 ;;^UTILITY(U,$J,358.3,11528,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11528,1,1,0)
 ;;=1^422.90
 ;;^UTILITY(U,$J,358.3,11528,1,2,0)
 ;;=2^MYOCARDITIS
 ;;^UTILITY(U,$J,358.3,11528,2)
 ;;=^269702
 ;;^UTILITY(U,$J,358.3,11529,0)
 ;;=728.86^^76^756^10
 ;;^UTILITY(U,$J,358.3,11529,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11529,1,1,0)
 ;;=1^728.86
 ;;^UTILITY(U,$J,358.3,11529,1,2,0)
 ;;=2^NECROTIZING FASCIITIS
 ;;^UTILITY(U,$J,358.3,11529,2)
 ;;=^303314
 ;;^UTILITY(U,$J,358.3,11530,0)
 ;;=730.20^^76^756^11
 ;;^UTILITY(U,$J,358.3,11530,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11530,1,1,0)
 ;;=1^730.20
 ;;^UTILITY(U,$J,358.3,11530,1,2,0)
 ;;=2^OSTEOMYELITIS NOS-UNSPEC
 ;;^UTILITY(U,$J,358.3,11530,2)
 ;;=^87108
 ;;^UTILITY(U,$J,358.3,11531,0)
 ;;=420.90^^76^756^12
 ;;^UTILITY(U,$J,358.3,11531,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11531,1,1,0)
 ;;=1^420.90
 ;;^UTILITY(U,$J,358.3,11531,1,2,0)
 ;;=2^PERICARDITIS
 ;;^UTILITY(U,$J,358.3,11531,2)
 ;;=^269692
 ;;^UTILITY(U,$J,358.3,11532,0)
 ;;=481.^^76^756^13
 ;;^UTILITY(U,$J,358.3,11532,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11532,1,1,0)
 ;;=1^481.
 ;;^UTILITY(U,$J,358.3,11532,1,2,0)
 ;;=2^PNEUMONIA,PNEUMOCOCCAL
 ;;^UTILITY(U,$J,358.3,11532,2)
 ;;=^95612
 ;;^UTILITY(U,$J,358.3,11533,0)
 ;;=480.0^^76^756^14
 ;;^UTILITY(U,$J,358.3,11533,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11533,1,1,0)
 ;;=1^480.0
 ;;^UTILITY(U,$J,358.3,11533,1,2,0)
 ;;=2^PNEUMONIA,VIRAL
 ;;^UTILITY(U,$J,358.3,11533,2)
 ;;=^269928
 ;;^UTILITY(U,$J,358.3,11534,0)
 ;;=486.^^76^756^15
 ;;^UTILITY(U,$J,358.3,11534,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11534,1,1,0)
 ;;=1^486.
 ;;^UTILITY(U,$J,358.3,11534,1,2,0)
 ;;=2^PNEUMONIA, ORGANISM NOS
 ;;^UTILITY(U,$J,358.3,11534,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,11535,0)
 ;;=038.9^^76^756^16
 ;;^UTILITY(U,$J,358.3,11535,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11535,1,1,0)
 ;;=1^038.9
 ;;^UTILITY(U,$J,358.3,11535,1,2,0)
 ;;=2^SEPSIS
 ;;^UTILITY(U,$J,358.3,11535,2)
 ;;=^109318
 ;;^UTILITY(U,$J,358.3,11536,0)
 ;;=995.90^^76^756^17
 ;;^UTILITY(U,$J,358.3,11536,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11536,1,1,0)
 ;;=1^995.90
 ;;^UTILITY(U,$J,358.3,11536,1,2,0)
 ;;=2^SYSTEM INFLAM RESPONSE SYNDROM
 ;;^UTILITY(U,$J,358.3,11536,2)
 ;;=^328611
 ;;^UTILITY(U,$J,358.3,11537,0)
 ;;=136.9^^76^756^18
 ;;^UTILITY(U,$J,358.3,11537,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11537,1,1,0)
 ;;=1^136.9
 ;;^UTILITY(U,$J,358.3,11537,1,2,0)
 ;;=2^OTH INFECTIOUS CONDITIONS
 ;;^UTILITY(U,$J,358.3,11537,2)
 ;;=^123934
 ;;^UTILITY(U,$J,358.3,11538,0)
 ;;=99377^^77^757^1^^^^1
 ;;^UTILITY(U,$J,358.3,11538,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11538,1,1,0)
 ;;=1^99377
 ;;^UTILITY(U,$J,358.3,11538,1,2,0)
 ;;=2^Hospice Care Supervision,15-29 min
 ;;^UTILITY(U,$J,358.3,11539,0)
 ;;=99378^^77^757^2^^^^1
 ;;^UTILITY(U,$J,358.3,11539,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11539,1,1,0)
 ;;=1^99378
 ;;^UTILITY(U,$J,358.3,11539,1,2,0)
 ;;=2^Hospice Care Supervision,30 min or more
